Publicaciones en colaboración con investigadores/as de University Hospital Heidelberg (9)

2024

  1. Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1

    Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133

2023

  1. PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2

    Kidney International, Vol. 103, Núm. 1, pp. 207-217

2018

  1. Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679] (S0168827817320469) (10.1016/j.jhep.2017.05.010))

    Journal of Hepatology

2017

  1. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction

    Journal of Hepatology, Vol. 67, Núm. 4, pp. 669-679

2014

  1. Doporuečené postupy European Renal Best Practice (ERBP) pro posuzování dárců a příjemců pro transplantaci ledviny a pro perioperační péči

    Aktuality v Nefrologii, Vol. 20, Núm. 2, pp. 78-85

  2. Guías Europeas sobre manejo y evaluación de receptores y donantes renales

    Nefrologia, Vol. 34, Núm. 3, pp. 293-301

2013

  1. Guideline

    Nephrology Dialysis Transplantation, Vol. 28, Núm. SUPPL.2

  2. Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies

    European Journal of Human Genetics, Vol. 21, Núm. 2, pp. 162-172

2012

  1. Liver cell transplantation in severe infantile oxalosisa potential bridging procedure to orthotopic liver transplantation?

    Nephrology Dialysis Transplantation, Vol. 27, Núm. 7, pp. 2984-2989